Ballysillan Health Care Ltd iXBRL

Ballysillan Health Care Ltd

Abridged Unaudited Financial Statements

for the financial year ended 31 May 2026

Ballysillan Health Care Ltd

Company Registration Number: NI687188

ABRIDGED BALANCE SHEET

as at 31 May 2026

		2026	2025
	Notes	£	£

Fixed Assets

Tangible assets

105,000

105,000

Investments

2,981,911

2,981,911

─────────

Fixed Assets

3,086,911

3,086,911

─────────

Current Assets

Cash at bank and in hand

261

346

Creditors: amounts falling due within one year

(1,589,192)

(1,621,359)

─────────

Net Current Liabilities

(1,588,931)

(1,621,013)

─────────

Total Assets less Current Liabilities

1,497,980

1,465,898

Creditors:

amounts falling due after more than one year

(1,196,583)

(1,247,927)

─────────

Net Assets

301,397

217,971

═════════

Capital and Reserves

Called up share capital

100

100

Retained earnings

301,297

217,871

─────────

Shareholders' Funds

301,397

217,971

═════════

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).

All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.

The company has taken advantage of the exemption under section 444 not to file the Abridged Profit and Loss Account and Directors' Report.

For the financial year ended 31 May 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The directors confirm that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Approved by the Board and authorised for issue on 14 September 2026 and signed on its behalf by




________________________________
Mr Ronald Badger
Director

Ballysillan Health Care Ltd

NOTES TO THE ABRIDGED FINANCIAL STATEMENTS

for the financial year ended 31 May 2026

General Information

Ballysillan Health Care Ltd is a private company limited by shares incorporated and registered in Northern Ireland. The registered number of the company is NI687188. The registered office of the company is 697 Oldpark Road, Belfast, BT14 6QY, Northern Ireland which is also the principal place of business of the company. The nature of the company's operations and its principal activities are set out in the Directors' Report. The financial statements have been presented in Pound (£) which is also the functional currency of the company.

The financial statements cover the individual entity, Ballysillan Health Care Ltd for the financial year ended 31st May 2026.

Summary of Significant Accounting Policies

The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.

Statement of compliance

The financial statements of the company for the financial year ended 31 May 2026 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.

Consolidated accounts

The company is entitled to the exemption in Section 399 of the Companies Act 2006 from the obligation to prepare group accounts.

Turnover

Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.

Tangible assets and depreciation

Tangible assets are stated at cost or at valuation, less accumulated depreciation. Cost comprises purchase price and other directly attributable costs. Freehold land is stated at cost and is not depreciated. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:

Land and buildings freehold

Not depreciated

The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.

Investments

Investments held as fixed assets are stated at cost less provision for any permanent diminution in value. Income from other investments together with any related tax credit is recognised in the Profit and Loss Account in the financial year in which it is receivable.

Borrowing costs

Borrowing costs relating to the acquisition of assets are capitalised at the appropriate rate by adding them to the cost of assets being acquired. Investment income earned on the temporary investment of specific borrowings pending their expenditure on the assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Taxation

Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Dividends

Dividends are recognised as a liability when the shareholders right to receive payment has been established.

Ordinary share capital

The ordinary share capital of the company is presented as equity.

Employees

The average monthly number of employees, including directors, during the financial year was


4.	Tangible assets
		Land and	Total
		buildings
		freehold
		£	£
	Cost
	At 1 June 2025	105,000	105,000
		─────────	─────────

	At 31 May 2026	105,000	105,000
		─────────	─────────
	Depreciation
	At 1 June 2025	-	-
		─────────	─────────
	At 31 May 2026	-	-
		─────────	─────────
	Net book value
	At 31 May 2026	105,000	105,000
		═════════	═════════
	At 31 May 2025	105,000	105,000
		═════════	═════════


5.	Investments
		Group and	Total
		participating
		interests/
		joint ventures
	Investments	£	£
	Cost

	At 31 May 2026	2,981,911	2,981,911
		─────────	─────────
	Net book value
	At 31 May 2026	2,981,911	2,981,911
		═════════	═════════
	At 31 May 2025	2,981,911	2,981,911
		═════════	═════════

Post-Balance Sheet Events

There have been no significant events affecting the company since the financial year-end.